Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic and Radiation Therapy Approaches for Locally Advanced Non–Small-Cell Lung Cancer
Kristin Higgins, Sonam Puri, Jhanelle E. Gray
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 576-585
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy
Tianchuan Zhu, Zhenxing Chen, Guanmin Jiang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16770-16786
Closed Access | Times Cited: 49
Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non–Small Cell Lung Cancer
Trudy C. Wu, Elaine Luterstein, Beth K. Neilsen, et al.
JAMA Oncology (2024) Vol. 10, Iss. 3, pp. 352-352
Closed Access | Times Cited: 10
N-acetyltransferase 10 impedes EZH2/H3K27me3/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation
Nan Xiao, Hongyang Liu, Ruike Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 139823-139823
Closed Access | Times Cited: 1
C1q+tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
Siyu Zhang, Wenbei Peng, Haolei Wang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e007441-e007441
Open Access | Times Cited: 21
New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
Jiaqi Feng, Pengpeng Zhang, Dingli Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Social support can alleviate the fear of cancer recurrence in postoperative patients with lung carcinoma.
Wei Zheng, Mengdie Hu, Yan Liu
PubMed (2022) Vol. 14, Iss. 7, pp. 4804-4811
Closed Access | Times Cited: 26
Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
Changshu Li, Jun Shao, Peiyi Li, et al.
Cancer Letters (2023) Vol. 577, pp. 216365-216365
Open Access | Times Cited: 15
LILRB2 inhibition enhances radiation sensitivity in non-small cell lung cancer by attenuating radiation-induced senescence
Xiaozheng Chen, Meng Yuan, Zhong Tao, et al.
Cancer Letters (2024) Vol. 593, pp. 216930-216930
Open Access | Times Cited: 5
Establishing a deep learning model that integrates pre- and mid-treatment computed tomography to predict treatment response for non-small cell lung cancer
Xuming Chen, Fanrui Meng, Ping Zhang, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Closed Access
Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathway
Jingjing Shi, Shaoyu Hao, Xiantao Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Cancer Driven Direct Medical Costs in Bangladesh: Evidence from Patient Perspective
Md. Shahjalal, Md. Parvez Mosharaf, Padam Kanta Dahal, et al.
Journal of Cancer Policy (2025), pp. 100565-100565
Closed Access
Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?
Jordi Remón, Antonin Lévy, Pawan Singh, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 14
Cu2+–Citrate–Chitosan Complex Nanoparticles for the Chemodynamic Therapy of Lung Cancer
Hechen Sun, Lening Zhang, Nan Zhao, et al.
ACS Omega (2024)
Open Access | Times Cited: 2
Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces
Zheng Xiang, Qiu Li, Ying Huang, et al.
Molecular Immunology (2024) Vol. 168, pp. 75-88
Closed Access | Times Cited: 2
Predictive value of primary tumor volume change during concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer
Hye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.
Radiotherapy and Oncology (2024) Vol. 198, pp. 110383-110383
Closed Access | Times Cited: 2
Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy
Xiaohong Xu, Gang Chen, Shaonan Fan, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 1, pp. 479-490
Open Access | Times Cited: 1
Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma
Tingting Zhang, Ruhua Chen, Xiangyu Su, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29290-e29290
Open Access | Times Cited: 1
Integrated serum pharmacochemistry, network pharmacology and experimental verification to explore the mechanism of Aconiti Lateralis Radix Praeparata in treatment of lung cancer
Wen Zhang, Shuhui Cai, W. Luan, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024), pp. 116472-116472
Closed Access | Times Cited: 1
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry
Wenxun Dong, Ying Luo, Daqian He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway
Mengjiao Xu, Chao Xu, Yu Qiu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Locally Advanced Lung Cancer
Sarah Soyeon Oh, George N. Botros, Milan Patel, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 3, pp. 533-555
Closed Access | Times Cited: 3
Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses
Jingyao Zhang, Yinuo Wang, Baowen Yuan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?
Trudy C. Wu, Lauren Smith, David Woolf, et al.
Seminars in Radiation Oncology (2023) Vol. 34, Iss. 1, pp. 56-63
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top